About 350K Medtronic defibrillators recalled

Medtronic recalled 348,616 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators because they might fail to deliver energy when high voltage therapy is needed, the FDA said July 18. 

The recall includes devices distributed between Oct. 13, 2017, and June 9, 2023. 

The implantable defibrillators detect and treat irregular heartbeats by producing an electric shock, but if that shock underperforms or does not happen, the malfunction "can lead to cardiac arrest, other serious injury or death," according to the FDA.

As of July 18, there have been 28 complaints, 22 injuries and zero deaths reported.

Medtronic told providers in May to not prophylactically replace devices and reprogram the high voltage therapy pathways.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars